72 related articles for article (PubMed ID: 2459727)
41. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
[TBL] [Abstract][Full Text] [Related]
42. Poliovirus and polio antibody assay in HEp-2 and Vero cell cultures.
Albrecht P; Enterline JC; Boone EJ; Klutch MJ
J Biol Stand; 1983 Apr; 11(2):91-7. PubMed ID: 6306012
[TBL] [Abstract][Full Text] [Related]
43. The standardization of vaccines: a discussion.
Perkins FT
Rev Infect Dis; 1984; 6 Suppl 2():S523-4. PubMed ID: 6740098
[TBL] [Abstract][Full Text] [Related]
44. A microtitre plate method for isolation and typing of poliovirus using a blue-cell ELISA.
Samuel D; Megson B; Strang M; Appleton H
J Virol Methods; 2000 Nov; 90(2):125-33. PubMed ID: 11064113
[TBL] [Abstract][Full Text] [Related]
45. Observations of the incidence of structural abnormalities in the chromosomes of WI-38 cells prepared for vaccine manufacture.
Allnutt BJ; Purnell DJ; Roberts B
Dev Biol Stand; 1976 Dec 13-15; 37():177-80. PubMed ID: 1031683
[TBL] [Abstract][Full Text] [Related]
46. Karyological characterization of WI-38 cells used in the production of vaccines.
Frieling KH; Hövel H
Dev Biol Stand; 1976 Dec 13-15; 37():181-4. PubMed ID: 1031684
[TBL] [Abstract][Full Text] [Related]
47. The standardization of infectivity titrations of poliovaccines--a WHO collaborative study.
Magrath DI; Seagroatt V
J Biol Stand; 1985 Apr; 13(2):159-66. PubMed ID: 3997898
[TBL] [Abstract][Full Text] [Related]
48. Choice of cell substrate for biological products.
Beale AJ
Adv Exp Med Biol; 1979; 118():83-97. PubMed ID: 227238
[No Abstract] [Full Text] [Related]
49. The impact of interfacial interactions on poliovirus infectivity in detergent-treated cell monolayer cultures.
Vanden Bossche G
Microbiol Res; 1995 Sep; 150(3):247-63. PubMed ID: 7551734
[TBL] [Abstract][Full Text] [Related]
50. Titration of poliovaccines: improvement of end-point microassays by means of dose-response curves.
Husson-van Vliet J
J Virol Methods; 1986 Apr; 13(1):9-20. PubMed ID: 3722311
[TBL] [Abstract][Full Text] [Related]
51. Quantification of cells cultured on 96-well plates.
Kueng W; Silber E; Eppenberger U
Anal Biochem; 1989 Oct; 182(1):16-9. PubMed ID: 2604040
[TBL] [Abstract][Full Text] [Related]
52. [Mitigation of the formalin vaccine virus].
NELIS P; LAFONTAINE A
C R Seances Soc Biol Fil; 1948 Jun; 142(11-12):856-8. PubMed ID: 18891707
[No Abstract] [Full Text] [Related]
53. A CONVENIENT METHOD FOR THE FORMOL TITRATION.
Northrop JH
J Gen Physiol; 1926 Jul; 9(6):767-9. PubMed ID: 19872291
[No Abstract] [Full Text] [Related]
54. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
55. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
Montagnon BJ; Nicolas AJ; Fanget B; Peyron L
Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
[TBL] [Abstract][Full Text] [Related]
56. Potency test of inactivated polio vaccines in guinea pigs.
Lapinleimu K; Stenvik M
Dev Biol Stand; 1981; 47():109-12. PubMed ID: 7014296
[TBL] [Abstract][Full Text] [Related]
57. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
58. Tissue culture of viruses (author's transl).
Can J Med Technol; 1974 Jun; 36(3):231 passim. PubMed ID: 4368290
[No Abstract] [Full Text] [Related]
59. [Test of the potency of trivalent oral polio vaccines: comparison of 2 methods of reading].
Chocarro LB; Manau MV
Rev Argent Microbiol; 1987; 19(2):65-9. PubMed ID: 2459727
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
